chugai pharmaceutical co ltd
(4519:Tokyo Stock Exchange)
Last --
Change Today 0.00 / 0.00%
Volume 0.0
4519 On Other Exchanges
4519 is not on other exchanges.
Symbol
Exchange
All times are local (Market data is delayed by at least 15 minutes).
Executive Profile*
Yasuhiro TsujiFormer Corporate Auditor, Chugai Pharmaceutical Co. Ltd. |
| Age | Total Calculated Compensation | This person is connected to 0 board members in 0 different organizations across 1 different industries. |
| -- | -- |
Background*
Dr. Yasuhiro Tsuji served as Vice President of Chugai Pharmaceutical Co. Ltd. Dr. Tsuji served as President of Chugai Clinical Research Center Co., Ltd., a subsidiary of Chugai Pharmaceutical Co. Ltd. He served as a Corporate Auditor at Chugai Pharmaceutical Co. Ltd. until March 27, 2013.
Corporate Headquarters*1-1 Nihonbashi-muromachi 2-chomeTokyo, -- 103-8324 Japan Phone: 81 3 3281 6611 Fax: 81 3 3281 2828 Board Members Memberships*Former Corporate Auditor
Education*There is no Education data available.Other Affiliations*There is no Company Affiliations data available. |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*There is no Total Compensation data available. |
*Data is at least as current as the most recent Definitive Proxy.
| Recently Viewed | |||
| 4519:JP | ¥2,422.00 JPY | -20.00 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Robert A. Bradway | Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee Amgen Inc. | $1.3M |
| Robert J. Hugin MBA | Chairman, Chief Executive Officer, President and Chairman of Executive Committee Celgene Corporation | $1.2M |
| Haruo Naito | Chief Executive Officer, President and Director Eisai Co., Ltd. | -- |
| F. Michael Ball | Chief Executive Officer, Director and Member of Science, Technology & Quality Committee Hospira Inc. | $993.3K |
| Daniel J. Abdun-Nabi | Chief Executive Officer, President, Director and Member of Strategic Operations Committee Emergent BioSolutions, Inc. | $860.3K | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Thornton, CO | IntuitPosted: Apr 29
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact CHUGAI PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
